Physician

Hosam Saad-Naguib, MD

According to 2025 Medicare claims, Hosam Saad-Naguib, MD (NPI: 1861473472) practices hematology/oncology in the Dalton, GA market, with the plurality of this provider's patient population coming from Whitfield, GA. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 30720-8394.

Saad-Naguib's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 564 traditional Medicare patients, billed 177,708 HCPCS/CPT codes, and received $3,097,382 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,653 prescription claims across 254 beneficiaries totaling $4,484,857 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 43 claims. Open Payments data shows 8 records totaling $195. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,183,705 to $3,097,382. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,006,391 to $4,484,857. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,249 to $2,482.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.1M2015 Medicare payment: $1,183,705 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,038,942 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,258,216 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,364,444 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,011,230 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,210,467 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,561,377 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,496,458 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,422,589 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,097,382 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015596139,292$1,183,705
2016592153,018$1,038,942
2017628206,975$1,258,216
2018628397,742$1,364,444
2019613346,653$2,011,230
2020561256,252$2,210,467
2021559349,699$2,561,377
2022559322,519$2,496,458
2023581173,419$2,422,589
2024564177,708$3,097,382

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.6M2015 Drug cost: $1,006,391 (USD; Tot_Drug_Cst)2016 Drug cost: $1,203,204 (USD; Tot_Drug_Cst)2017 Drug cost: $1,383,984 (USD; Tot_Drug_Cst)2018 Drug cost: $2,163,533 (USD; Tot_Drug_Cst)2019 Drug cost: $2,678,355 (USD; Tot_Drug_Cst)2020 Drug cost: $3,681,863 (USD; Tot_Drug_Cst)2021 Drug cost: $4,159,829 (USD; Tot_Drug_Cst)2022 Drug cost: $4,605,728 (USD; Tot_Drug_Cst)2023 Drug cost: $4,270,656 (USD; Tot_Drug_Cst)2024 Drug cost: $4,484,857 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152131,419$1,006,391
20162091,365$1,203,204
20172061,569$1,383,984
20181931,618$2,163,533
20192221,583$2,678,355
20202461,720$3,681,863
20212401,744$4,159,829
20222221,668$4,605,728
20232241,427$4,270,656
20242541,653$4,484,857

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$12K$24K2015 Medicare payment: $24,310 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,210 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,827 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,884 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,233 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,126 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,702 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,344 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201531193$24,310
20161262$5,210
2017N/R11$1,827
2018N/R12$1,884
2019N/R12$1,233
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R24$1,126
2023N/R38$1,702
2024N/R43$2,344

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more142374$140
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more401836$90
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's198297$13
36415Insertion of needle into vein for collection of blood sample4813,213$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4843,587$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate491,470$859,887
PomalystPomalidomide26728$556,146
RevlimidLenalidomide26728$476,083
ImbruvicaIbrutinib25700$402,460
BrukinsaZanubrutinib22660$316,766

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R23$1,634
E1392Portable oxygen concentrator, rentalYN/R20$711

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$195TerSera Therapeutics LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Hosam Saad-Naguib, MD?

Tedicare shows public-source Medicare data for Hosam Saad-Naguib, MD (NPI 1861473472), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hosam Saad-Naguib, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hosam Saad-Naguib, MD?

Hosam Saad-Naguib, MD is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Hosam Saad-Naguib, MD have Open Payments data?

Hosam Saad-Naguib, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.